<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai J</submitter><funding>National Natural Science Foundation of China</funding><pagination>101391</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8920937</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19</volume><pubmed_abstract>Glioblastoma multiforme (GBM) is the most common and most fatal primary malignant brain tumour in adults. The average survival time of patients after diagnosis is only 12-15 months. And its characteristics of excessive proliferation and apoptosis evasion play a crucial role in the poor prognosis of patients. Therefore, it is worth investigating the molecular mechanism of GBM to find an effective therapeutic target to overcome the dilemma. In the current study, Transmembrane BAX inhibitor motif containing 1 (TMBIM1) was highly expressed in GBM tissues and high TMBIM1 expression in GBM cell lines (U87 and U251) could promote cell proliferation and inhibit cell cycle arrest. In addition, TMBIM1 could significantly attenuate GBM cell apoptosis and decrease the sensitivity of GBM cells to temoz</pubmed_abstract><journal>Translational oncology</journal><pubmed_title>TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway.</pubmed_title><pmcid>PMC8920937</pmcid><funding_grant_id>82072764</funding_grant_id><funding_grant_id>81572489</funding_grant_id><pubmed_authors>Tong S</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Jiang H</pubmed_authors><pubmed_authors>Cai J</pubmed_authors><pubmed_authors>Yan T</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Ye Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Gao L</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway.</name><description>Glioblastoma multiforme (GBM) is the most common and most fatal primary malignant brain tumour in adults. The average survival time of patients after diagnosis is only 12-15 months. And its characteristics of excessive proliferation and apoptosis evasion play a crucial role in the poor prognosis of patients. Therefore, it is worth investigating the molecular mechanism of GBM to find an effective therapeutic target to overcome the dilemma. In the current study, Transmembrane BAX inhibitor motif containing 1 (TMBIM1) was highly expressed in GBM tissues and high TMBIM1 expression in GBM cell lines (U87 and U251) could promote cell proliferation and inhibit cell cycle arrest. In addition, TMBIM1 could significantly attenuate GBM cell apoptosis and decrease the sensitivity of GBM cells to temoz</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T20:51:37.616Z</modification><creation>2025-04-04T20:51:37.616Z</creation></dates><accession>S-EPMC8920937</accession><cross_references><pubmed>35279540</pubmed><doi>10.1016/j.tranon.2022.101391</doi></cross_references></HashMap>